$18.22
At close: Jul 15, 5:49 PM EDT
$18.19
-0.03-0.16%
After Hours: 5:49 PM EDT
Comments
Loading...
XP Analyst Ratings and Price Targets | NASDAQ:XP | Benzinga
XP Inc has a consensus price target of $24.89 based on the ratings of 9 analysts. The high is $32 issued by Banco Bradesco BBI S.A on January 24, 2024. The low is $19 issued by B of A Securities on May 21, 2025. The 3 most-recent analyst ratings were released by UBS, Goldman Sachs, and Goldman Sachs on June 10, 2025, June 4, 2025, and May 21, 2025, respectively. With an average price target of $21.33 between UBS, Goldman Sachs, and Goldman Sachs, there's an implied 17.28% upside for XP Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
Goldman Sachs
B of A Securities
Morgan Stanley
JP Morgan
1calculated from analyst ratings
Analyst Ratings for XP
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
06/10/2025 | 31.94% | UBS | $17 → $24 | Maintains | Buy | |||
06/04/2025 | 26.44% | Goldman Sachs | $17 → $23 | Upgrade | Neutral → Buy | |||
05/21/2025 | -6.54% | Goldman Sachs | $15 → $17 | Maintains | Neutral | |||
05/21/2025 | 4.45% | B of A Securities | $16 → $19 | Maintains | Neutral | |||
05/13/2025 | 31.94% | Morgan Stanley | $18 → $24 | Upgrade | Equal-Weight → Overweight | |||
04/07/2025 | -6.54% | UBS | $16 → $17 | Maintains | Buy | |||
01/27/2025 | -28.53% | Goldman Sachs | $19 → $13 | Maintains | Neutral | |||
01/24/2025 | -12.04% | UBS | $19 → $16 | Upgrade | Neutral → Buy | |||
12/10/2024 | -12.04% | B of A Securities | $25 → $16 | Downgrade | Buy → Neutral | |||
11/26/2024 | 15.45% | Morgan Stanley | $24 → $21 | Maintains | Equal-Weight | |||
11/25/2024 | 4.45% | UBS | $21 → $19 | Maintains | Neutral | |||
10/16/2024 | 59.43% | JP Morgan | $28 → $29 | Maintains | Overweight | |||
07/30/2024 | 4.45% | Goldman Sachs | $22 → $19 | Maintains | Neutral | |||
07/11/2024 | 15.45% | UBS | $30 → $21 | Downgrade | Buy → Neutral | |||
06/17/2024 | 37.44% | B of A Securities | $31 → $25 | Maintains | Buy | |||
06/05/2024 | 48.43% | Citigroup | $29 → $27 | Maintains | Buy | |||
04/30/2024 | 26.44% | Goldman Sachs | $30 → $23 | Downgrade | Buy → Neutral | |||
04/23/2024 | 31.94% | Morgan Stanley | $31 → $24 | Downgrade | Overweight → Equal-Weight | |||
03/22/2024 | 59.43% | Citigroup | $28 → $29 | Maintains | Buy | |||
01/24/2024 | 75.92% | Banco Bradesco BBI S.A | → $32 | Upgrade | Neutral → Outperform | |||
12/05/2023 | 64.93% | JP Morgan | $27 → $30 | Upgrade | Neutral → Overweight | |||
09/01/2023 | 81.42% | UBS | $28 → $33 | Maintains | Buy | |||
08/23/2023 | 48.43% | JP Morgan | $18.5 → $27 | Maintains | Neutral | |||
08/21/2023 | 64.93% | Citigroup | $20 → $30 | Maintains | Buy | |||
07/20/2023 | 42.94% | Credit Suisse | $15 → $26 | Upgrade | Underperform → Neutral | |||
07/10/2023 | 59.43% | Goldman Sachs | $22 → $29 | Maintains | Buy | |||
06/22/2023 | — | B of A Securities | — | Upgrade | Neutral → Buy | |||
05/18/2023 | -6.54% | Banco Bradesco BBI S.A | $25 → $17 | Downgrade | Outperform → Neutral | |||
05/16/2023 | 20.95% | Goldman Sachs | $20 → $22 | Maintains | Buy | |||
03/31/2023 | 15.45% | UBS | $28 → $21 | Maintains | Buy | |||
03/02/2023 | 9.95% | Goldman Sachs | $30 → $20 | Maintains | Buy | |||
02/28/2023 | 9.95% | HSBC | $26 → $20 | Maintains | Buy | |||
02/27/2023 | 4.45% | Citigroup | $24 → $19 | Maintains | Buy | |||
02/17/2023 | -17.54% | Credit Suisse | $27 → $15 | Downgrade | Neutral → Underperform | |||
01/18/2023 | 64.93% | Goldman Sachs | $35 → $30 | Maintains | Buy | |||
11/28/2022 | 92.41% | Goldman Sachs | $40 → $35 | Maintains | Buy | |||
10/13/2022 | 119.9% | Goldman Sachs | $46 → $40 | Maintains | Buy | |||
08/16/2022 | 119.9% | Goldman Sachs | $46 → $40 | Maintains | Buy | |||
08/11/2022 | 26.44% | JP Morgan | → $23 | Downgrade | Overweight → Neutral |
FAQ
What is the target price for XP (XP) stock?
The latest price target for XP (NASDAQ:XP) was reported by UBS on June 10, 2025. The analyst firm set a price target for $24.00 expecting XP to rise to within 12 months (a possible 31.94% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for XP (XP)?
The latest analyst rating for XP (NASDAQ:XP) was provided by UBS, and XP maintained their buy rating.
When was the last upgrade for XP (XP)?
The last upgrade for XP Inc happened on June 4, 2025 when Goldman Sachs raised their price target to $23. Goldman Sachs previously had a neutral for XP Inc.
When was the last downgrade for XP (XP)?
The last downgrade for XP Inc happened on December 10, 2024 when B of A Securities changed their price target from $25 to $16 for XP Inc.
When is the next analyst rating going to be posted or updated for XP (XP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of XP, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for XP was filed on June 10, 2025 so you should expect the next rating to be made available sometime around June 10, 2026.
Is the Analyst Rating XP (XP) correct?
While ratings are subjective and will change, the latest XP (XP) rating was a maintained with a price target of $17.00 to $24.00. The current price XP (XP) is trading at is $18.19, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
